Saratoga Ventures

Saratoga Ventures was a venture capital firm based in Mountain View, California, specializing in investments across various stages, including seed, early, and later stages. The firm focused on companies in the healthcare, biotechnology, pharmaceutical, and health technology sectors. Through its strategic investments, Saratoga Ventures aimed to support the growth of innovative companies within these industries.

Lee Stoian

General Partner

9 past transactions

Strategikon Pharma

Series A in 2021
Strategikon Pharma, Inc. is a technology company based in San Rafael, California, founded in 2016. It specializes in developing software solutions that streamline the outsourcing processes between sponsors and providers in the pharmaceutical industry. Its flagship product, Clinical Maestro, is a comprehensive software platform designed for the end-to-end management of clinical business operations, including planning, outsourcing, and budgeting for clinical trials. This innovative software replaces traditional, labor-intensive methods, often reliant on Excel, which are costly and inefficient. Clinical Maestro integrates workflows to enhance communication and data sharing between biopharmaceutical companies and their outsourcing partners. The platform facilitates clinical financial management, vendor performance metrics, and contract lifecycle management, while also offering consulting services for new clinical business operations. Case studies with leading pharmaceutical companies have shown that Clinical Maestro can lead to significant savings and improved accuracy in budgeting, demonstrating its effectiveness in transforming clinical trial management.

MyoScience

Series E in 2013
MyoScience Inc., founded in 2005 and based in Redwood City, California, focuses on the development and commercialization of innovative dermatological products. The company leverages advanced technology to create solutions aimed at addressing various skin-related issues. Through its efforts, MyoScience aims to provide effective products that enhance skin health and appearance.

MyoScience

Series D in 2012
MyoScience Inc., founded in 2005 and based in Redwood City, California, focuses on the development and commercialization of innovative dermatological products. The company leverages advanced technology to create solutions aimed at addressing various skin-related issues. Through its efforts, MyoScience aims to provide effective products that enhance skin health and appearance.

FRP Products

Private Equity Round in 2011
FRP Products specializes in providing surface preparation and corrosion protection services primarily for the oil, petrochemical, and pharmaceutical industries. The company offers a range of services, including fiberglass lamination and repair, protective coating applications, tank-lining applications, thermal spray coating, factory blasting and painting, dust-free abrasive blast cleaning, as well as scaffolding and insulation works. With a focus on enhancing the durability and safety of industrial facilities, FRP Products caters to the specific needs of its clients, ensuring reliable and efficient service delivery in critical sectors.

Tibion Bionic Technologies

Series A in 2010
Tibion Corporation is a medical device company based in Moffett Field, California, specializing in the design and development of bionic devices aimed at enhancing mobility for individuals with impairments. Founded in 2002, the company focuses on non-invasive technologies that provide actively-assisted mobility enhancement and rehabilitation for those recovering from surgeries, strokes, or experiencing age-related muscle loss. Its flagship product, the PowerKnee, is a wearable bionic device designed to support leg rehabilitation, improve muscle strength, and assist users in daily activities. By leveraging advancements in orthotics, biomechanics, and embedded control systems, Tibion's products aim to significantly improve the quality of life for individuals with lower extremity dysfunction.

Hotspur Technologies

Series A in 2008
Hotspur Technologies is a prominent developer of catheter-based technologies designed to restore blood flow in patients with obstructed vessels. The company's innovative products utilize advanced technology to facilitate more efficient and less invasive procedures for opening blood vessels. By focusing on improving patient outcomes through its unique solutions, Hotspur Technologies aims to address critical challenges in vascular health.

MyoScience

Series B in 2008
MyoScience Inc., founded in 2005 and based in Redwood City, California, focuses on the development and commercialization of innovative dermatological products. The company leverages advanced technology to create solutions aimed at addressing various skin-related issues. Through its efforts, MyoScience aims to provide effective products that enhance skin health and appearance.

Broncus Medical

Series F in 2006
Broncus Medical is a medical technology company specializing in the development of minimally-invasive devices for treating lung diseases, including emphysema and lung cancer. Based in Mountain View, California, with an international presence in Nyon, Switzerland, Broncus is focused on addressing significant unmet medical needs in interventional pulmonology. The company is exploring its Exhale product line, which features a patented treatment method known as Airway Bypass, aimed at providing a minimally-invasive solution for patients suffering from homogeneous emphysema. Broncus is currently conducting the pivotal EASE Trial, enrolling patients worldwide to evaluate the efficacy of this treatment in severe cases of the disease. Additionally, Broncus offers a range of innovative products designed to enhance diagnostic and therapeutic outcomes in lung care, including the Archimedes System, LungPoint, and InterVapor System.

Intact Medical

Series D in 2003
Intact Medical Corporation is a medical device company based in Framingham, Massachusetts, specializing in the design, development, and marketing of minimally invasive systems for volumetric excision of tissue, particularly for diagnostic and therapeutic applications in cancer care. Founded in 1998 and originally known as Neothermia Corporation, the company has a mission to alleviate pain, restore health, and extend life. Its flagship product is a breast lesion excision system that employs vacuum-assisted, image-guided technology. This system allows for the removal of intact samples of suspicious tissue through a small incision, utilizing radio frequency energy to ensure complete excision of abnormalities. By focusing on minimally invasive procedures, Intact Medical aims to enhance patient outcomes and streamline the diagnostic process in oncology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.